| | | Index Performance | | Index | Sensex | Nifty | | Open | 12,694.36 | 3,768.40 | | High | 12,694.36 | 3,768.40 | | Low | 12,504.10 | 3,623.00 | | Today's Cls | 12,529.62 | 3,641.10 | | Prev Cls | 12,982.98 | 3,770.55 | | Change | -453.36 | -129.45 | | % Change | -3.49 | -3.43 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | iGate Global | 359.75 | 5.08 | | India Cement | 158.90 | 3.38 | | Micro Inks | 331.30 | 2.98 | | CMC | 1,230.25 | 1.14 | | CESC | 340.00 | 1.12 | | Losers | | Lanco Infra | 178.60 | -8.08 | | Torrent Pharma | 186.10 | -7.41 | | Sterling Biotech | 150.05 | -6.37 | | Bombay Dyeing | 540.80 | -6.35 | | IDFC | 83.35 | -6.19 | | | Market Statistics | | - | BSE | NSE | | Advances | 740 | 297 | | Declines | 1,772 | 1,057 | | Unchanged | 66 | 24 | | Volume(Nos) | 20.73cr | 33.93cr | | | | | | Market Commentary | | | Sensex crashes on global meltdown | | Across-the-board selling pressure led by the banking stocks saw the Sensex plummet 3.49%. | | Sub-prime mortgage sector woes triggering the heavy sell-off in US equities, suggesting a slowdown in the US economy and unwinding of the yen carry trades put | | | pressure on Asian as well as domestic indices. The Sensex began the day deep in the red with a negative gap of 289 points at 12694 and remained range-bound with a negative bias throughout the session. The Sensex slipped further in the afternoon on unabated selling in banking, information technology and oil stocks to touch an intra-day low of 12504, down 479 points. The Sensex managed to pare some losses towards the close and ended the session with losses of 453 points or 3.49% at 12530. The Nifty shed 129 points and closed at 3641.
The breadth of the market was extremely negative. Of the 2,578 stocks traded on the BSE, 1,772 stocks declined, 740 stocks advanced and 60 stocks ended unchanged. All the sectoral indices came under sharp hammering and shed 2-4% each. Among the heavy losers, the BSE Bankex, the BSE Teck Index and the BSE IT Index dropped 3-4% each. | | | Movers & Shakers | - Elder Pharmaceuticals gained on reports that the company has entered into an alliance with a Spanish company to market advanced heparins (anti-thrombotics) in India.
- Biocon moved up on reports that its subsidiary Syngene has entered into a partnership with Bristol-Myers Squibb for research.
- Gayatri Projects slipped despite securing four new orders amounting to Rs192 crore.
- Nagarjuna Construction Company moved down despite securing orders amounting to Rs348 crore.
| | | |
Except Bajaj Auto and Gujarat Ambuja Cement all the Sensex stocks closed weak. ICICI Bank plunged 5.43% at Rs830, Bharti Airtel slipped 4.72% at Rs729, Wipro dipped 4.58% at Rs555, Reliance Communications plummeted 4.36% at Rs398, Satyam Computers slumped 4.30% at Rs433, ITC lost 4.13% at Rs143, Infosys tumbled 4.11% at Rs2,019, BHEL fell 4.10% at Rs2,030, TCS shed 4.03% at Rs1,214 and Tata Motors was down 3.63% at Rs745. The other front-line stocks shed 2-3% each.
Banking stocks slipped sharply following weak global markets. Bank of India plunged 6% at Rs140, Oriental Bank shed 5.43% at Rs162, Allahabad Bank lost 3.69% at Rs72 and Indian Overseas Bank fell 3.53% at Rs94. UTI Bank, State Bank of India, Canara Bank, Bank of Baroda and HDFC Bank were down 2-3% each.
Over 77.63 lakh Idea Cellular shares changed hands on the BSE followed by Parsvanath Developers (43.37 lakh shares), ITC (32.80 lakh shares), India Cements (27.85 lakh shares) and Gujarat Ambuja Cement (27.67 lakh shares).
Parsvanath Developers registered a turnover of Rs129 crore on the BSE followed by Reliance Industries (Rs112 crore), Reliance Communications (Rs98 crore), ACC (Rs92 crore) and Infosys (Rs89 crore).
| | | | | | | | European Indices at 16:00 IST on 14-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6067.00 | -94.20 | -1.53 | | CAC 40 Index | 5350.56 | -82.38 | -1.52 | | DAX Index | 6519.12 | -104.87 | -1.58 | | | | | | | | | | | Asian Indices at close on 14-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 16676.89 | -501.95 | 2.92 | | Hang Seng Index | 18836.93 | -496.21 | -2.57 | | Kospi Index | 1407.37 | -28.68 | -2.00 | | Straits Times Index | 3053.21 | -105.69 | -3.35 | | Jakarta Composite Index | 1762.28 | -35.12 | -1.95 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment